License,Industries,Plate,Rico,Tag,,Fan,stephane-giberne.fr,Denver,NFL,/inflammability889477.html,Metal,#1,Bronc,Automotive , Exterior Accessories , License Plate Covers Frames,$11 License,Industries,Plate,Rico,Tag,,Fan,stephane-giberne.fr,Denver,NFL,/inflammability889477.html,Metal,#1,Bronc,Automotive , Exterior Accessories , License Plate Covers Frames,$11 $11 NFL Rico Industries #1 Fan Metal License Plate Tag, Denver Bronc Automotive Exterior Accessories License Plate Covers Frames NFL Rico Industries #1 Fan Metal Factory outlet Plate Denver License Tag Bronc $11 NFL Rico Industries #1 Fan Metal License Plate Tag, Denver Bronc Automotive Exterior Accessories License Plate Covers Frames NFL Rico Industries #1 Fan Metal Factory outlet Plate Denver License Tag Bronc

NFL Rico Industries Max 64% OFF #1 Fan Metal Factory outlet Plate Denver License Tag Bronc

NFL Rico Industries #1 Fan Metal License Plate Tag, Denver Bronc

$11

NFL Rico Industries #1 Fan Metal License Plate Tag, Denver Bronc

|||

Product description

Go ahead and display for all to see that you are the #1 Fan with this #1 Fan Metal License Plate Tag by Rico Industries. This team colored license plate tag measures 6-inches by 12.25-inches and is decorated with bold and vibrant team colored graphics. It boasts embossed lettering to create a dynamic statement. It is made of durable metal construction that is built to withstand the outside elements. It features pre-drilled holes for easy installation. Officially licensed, makes for an ideal gift.

NFL Rico Industries #1 Fan Metal License Plate Tag, Denver Bronc

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA